Shigeo Ohba

10PUBLICATIONS
39CO-AUTHORS
Predictive and prognostic markersOther environmental sciences not elsewhere classifiedMolecular targetsPacific Peoples life courseCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|Aug 21, 2026
Role of antiseizure medication in postoperative late seizure and survival among patients with newly diagnosed glioblastoma: A multicenter retrospective study.

|Jul 20, 2026
Ependymoma-like tumor with mesenchymal differentiation harboring ZFTA::NCOA2 fusion: a case report.

|Nov 29, 2025
Targeting distinct amino acid metabolic vulnerabilities in IDH-mutant and IDH-wildtype gliomas.

Shigeo Ohba, Akiyoshi Hirayama, Takao Teranishi

|Jan 11, 2025
Factors involved in maintaining Karnofsky Performance Status (≥ 50%) in glioblastoma, IDH-wildtype patients treated with temozolomide and radiotherapy.

Shigeo Ohba, Takao Teranishi, Kazuyasu Matsumura

|Feb 11, 2023
Three-Dimensional Amide Proton Transfer-Weighted Imaging for Differentiating between Glioblastoma, IDH-Wildtype and Primary Central Nervous System Lymphoma.

Shigeo Ohba, Kazuhiro Murayama, Takao Teranishi

|Jun 02, 2021
Inhibition of DNA Repair in Combination with Temozolomide or Dianhydrogalactiol Overcomes Temozolomide-Resistant Glioma Cells.

Shigeo Ohba, Kei Yamashiro, Yuichi Hirose

Pageof 2

Frequent Collaborators

3 joint publications

Yuichi Hirose

2 joint publications

Russell O Pieper

1 joint publications

Ajay Pandita

1 joint publications

Chatla Kamalakar